2022年10月20日

。新闻分享这篇文章提供的具有里程碑意义的通知2022生殖医学大会我们正在帮助改变生育和怀孕早期护理通过应用高度发达,具有成本效益的移动成像技术。”——Liteng徐,LinkMed首席执行官洛杉矶CA,美国,10月20日2022 / EINPresswire.com——第一次在美国女性获得家庭和在职医疗监测生育和怀孕早期,由于开创性医疗初创公司——LinkMed的形成。移动医疗解决方案的代表联系,Inc . (LinkMed)具有里程碑意义的科学大会宣布在2022年10月美国生殖医学协会(ASRM)在阿纳海姆,加利福尼亚州。新公司,被称为LinkMed (https://www.linkmed-inc.com),成为全国第一个提供远程医学成像监测一个女人的生育和怀孕早期状态——服务从未在美国生殖医学领域。该公司将执行的具体性和血液从病人的安慰自己的家庭或其他设置,比如在职的办公室,方便患者。“我们正在帮助改变生育和怀孕早期护理通过应用高度发达,具有成本效益的移动成像技术给临床医生信息更为可靠的从传统的方法和系统,获得“LinkMed CEO Liteng徐说。“我们的移动技术创造更清晰,高质量扫描更多的诊断价值。“LinkMed软件平台也为基础发展的一个新的、强大的应用程序连接生育和怀孕患者临床提供者,超级连接其司机和乘客,徐说。“医生能够使用这个平台做笔记对成像结果和警报的病人。 Patients, too, can access the software to comment on findings and query their providers.” As an at-home diagnostic provider, LinkMed employs skilled phlebotomists and accredited, registered diagnostic medical sonographers who specialize in fertility and pregnancy assessment in remote locations. Patients have the option of making appointments online, by phone, or by email. After the scanning is performed, the platform sends results via email to both patients and their doctors and stores the information in a secure LinkMed portal, readily accessible to patients. The company is entering a global fertility market where demand in general for convenient, portable, and remote medical technology and services is growing exponentially. A recent industry report from Mordor Intelligence attributes this demand as one reason for the mobile imaging market’s forecasted annual compound growth rate of 5.1 percent between now and 2027. Earlier this year (2022), growth strategy consulting firm Frost & Sullivan indicated mobile medical systems offer “rapid, accurate, and effective diagnosis…with the ability to improve patients’ health outcomes.” Other experts cite the safety and flexibility in scheduling of mobile imaging technology. LinkMed’s entry into the mobile imaging market taps an unmet need among U.S. patients requiring fertility and pregnancy monitoring, Xu said. The company currently offers four major areas of service: • Assessment of patients who desire to know their current fertility status. Such information is particularly useful for potential egg donors, cancer patients, and those considering the possibility of invitro fertilization (IVF). • In-cycle IVF monitoring because IVF patients, including surrogates, must undergo regular monitoring for the duration of their cycle. • Post-operative evaluation of patients who have undergone a fertilization procedure, such as egg retrieval or transfer. • Monitoring of early pregnancies – up to 14 weeks gestation. • Because proper fertility monitoring involves both scanning and blood assessment, LinkMed offers same-day, at-home blood draws and testing. The blood is evaluated for hormone levels to ensure the best chances of a successful pregnancy. Although LinkMed now serves only California and bordering cities in Nevada, representatives indicate the company is positioned to grow rapidly to other parts of the country, beginning in 2023. Link Mobile Medical Solution, Inc., doing business as LinkMed, is the first provider of at-home mobile medical imaging for fertility and early pregnancy patients in the U.S. Although LinkMed pregnancy monitoring currently ends at 14 weeks, gestation, the company plans eventually to expand its services to address all obstetrics and gynecology needs. https://www.linkmed-inc.com Geoffrey Hawes